{
  "ticker": "GILD",
  "last_updated": "2025-04-19T08:46:13.654982",
  "retention_years": 3,
  "count": 271,
  "transactions": [
    {
      "id": 190811,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Bluestone Jeffrey",
      "reporting_owner_cik": "0001771814",
      "reporting_owner_position": null,
      "transaction_date": "2024-11-26",
      "transaction_shares": "5879",
      "transaction_price": "61.17",
      "transaction_type": "M",
      "shares_after_transaction": "11587"
    },
    {
      "id": 190846,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "5000",
      "transaction_price": "91.28",
      "transaction_type": "S",
      "shares_after_transaction": "73127"
    },
    {
      "id": 190850,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-11-06",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "125189"
    },
    {
      "id": 160589,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 190824,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-10-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21221"
    },
    {
      "id": 160603,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 190838,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-10-01",
      "transaction_shares": "2000",
      "transaction_price": "83.83",
      "transaction_type": "S",
      "shares_after_transaction": "100189"
    },
    {
      "id": 132717,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 132742,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 160578,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 160605,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 190813,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "25000",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "123435"
    },
    {
      "id": 190840,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-12",
      "transaction_shares": "15925",
      "transaction_price": "84.23",
      "transaction_type": "S",
      "shares_after_transaction": "91559"
    },
    {
      "id": 132718,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 132731,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 132733,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 132741,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 132743,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 132745,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 160579,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 160593,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 160595,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 160604,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 160606,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 160608,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 190814,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-09-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36877"
    },
    {
      "id": 190828,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3752",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "109218"
    },
    {
      "id": 190830,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3821",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100201"
    },
    {
      "id": 190839,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-09-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "500744"
    },
    {
      "id": 190841,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-09-10",
      "transaction_shares": "639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21014"
    },
    {
      "id": 190843,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-09-10",
      "transaction_shares": "3641",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "140601"
    },
    {
      "id": 132726,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 160587,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 190822,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-28",
      "transaction_shares": "9513",
      "transaction_price": "78.03",
      "transaction_type": "S",
      "shares_after_transaction": "105466"
    },
    {
      "id": 106837,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 132747,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 160610,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 190845,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-08-13",
      "transaction_shares": "5490",
      "transaction_price": "73.98",
      "transaction_type": "S",
      "shares_after_transaction": "114979"
    },
    {
      "id": 106842,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 132752,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 160615,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 190852,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-08-10",
      "transaction_shares": "3678",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "36956"
    },
    {
      "id": 82894,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 106833,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 132739,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 160601,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 190836,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-07-25",
      "transaction_shares": "2917",
      "transaction_price": "76.51",
      "transaction_type": "F",
      "shares_after_transaction": "11631"
    },
    {
      "id": 82890,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 106829,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 132735,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 160597,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 190832,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-07-01",
      "transaction_shares": "2000",
      "transaction_price": "68.63",
      "transaction_type": "S",
      "shares_after_transaction": "96380"
    },
    {
      "id": 61286,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 61290,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 61296,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 61301,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 61304,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 61306,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 82878,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 82882,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 82888,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 82895,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 82898,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 82900,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 106817,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 106821,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 106827,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 106834,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 106838,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 106840,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 132720,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 132724,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 132732,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 132740,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 132748,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 132750,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 160581,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 160585,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 160594,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 160602,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 160611,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 160613,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 190816,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3751",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "122183"
    },
    {
      "id": 190820,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-06-10",
      "transaction_shares": "638",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14752"
    },
    {
      "id": 190829,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-06-10",
      "transaction_shares": "10295",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "495142"
    },
    {
      "id": 190837,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3639",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "138622"
    },
    {
      "id": 190847,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-06-10",
      "transaction_shares": "901",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "33533"
    },
    {
      "id": 190849,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-06-10",
      "transaction_shares": "3820",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "100124"
    },
    {
      "id": 41963,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 41966,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 41971,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 41972,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 41984,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 61282,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 61285,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 61292,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 61293,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 61310,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 82874,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 82877,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 82884,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 82885,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 82904,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 106813,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 106816,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 106823,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 106824,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 106845,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 132714,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 132719,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 132727,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 132728,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 132755,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 160575,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 160580,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 160588,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 160590,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 160618,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 190809,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "WELTERS ANTHONY",
      "reporting_owner_cik": "0001213307",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10232"
    },
    {
      "id": 190815,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "MANWANI HARISH",
      "reporting_owner_cik": "0001527726",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "13324"
    },
    {
      "id": 190823,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Rodriguez Javier",
      "reporting_owner_cik": "0001415548",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10702"
    },
    {
      "id": 190825,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "BARTON JACQUELINE K",
      "reporting_owner_cik": "0001183680",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "24540"
    },
    {
      "id": 190855,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "2310",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "2822"
    },
    {
      "id": 41979,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 61303,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 82897,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 106836,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 132746,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 160609,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 190844,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-04-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14272"
    },
    {
      "id": 25652,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 41967,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 61287,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 82879,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 106818,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 132721,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 160582,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 190817,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "2000",
      "transaction_price": "72.96",
      "transaction_type": "S",
      "shares_after_transaction": "96304"
    },
    {
      "id": 13074,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 13077,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 13079,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 13083,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 13085,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 13089,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 25650,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 25654,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 25656,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 25660,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 25663,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 25667,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 41962,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 41969,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 41973,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 41978,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 41982,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 41988,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 61281,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 61289,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 61294,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 61302,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 61308,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 61314,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 82873,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 82881,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 82886,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 82896,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 82902,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 82908,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 106812,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 106820,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 106825,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 106835,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 106843,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 106849,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 132713,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 132723,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 132729,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 132744,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 132753,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 132759,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 160574,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 160584,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 160591,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 160607,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 160616,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 160622,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 190808,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2024-03-10",
      "transaction_shares": "748",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "31488"
    },
    {
      "id": 190819,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3455",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "96161"
    },
    {
      "id": 190826,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "116172"
    },
    {
      "id": 190842,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-03-10",
      "transaction_shares": "3025",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "132781"
    },
    {
      "id": 190853,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-03-10",
      "transaction_shares": "10800",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "479489"
    },
    {
      "id": 190859,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-03-10",
      "transaction_shares": "2555",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "14603"
    },
    {
      "id": 13087,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 25665,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 41986,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 61312,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 82906,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 106847,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 132757,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 160620,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 190857,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-02-28",
      "transaction_shares": "2000",
      "transaction_price": "73.18",
      "transaction_type": "S",
      "shares_after_transaction": "100936"
    },
    {
      "id": 3948,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 13075,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 25651,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 41964,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 61283,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 82875,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 106814,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 132715,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 160576,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 190810,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "LOVE TED W",
      "reporting_owner_cik": "0001188919",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-02",
      "transaction_shares": "512",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "512"
    },
    {
      "id": 3949,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 3951,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 3952,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 3953,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 3954,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 13076,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 13080,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 13081,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 13082,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 13084,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 25653,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 25657,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 25658,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 25659,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 25662,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 41968,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 41974,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 41976,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 41977,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 41981,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 61288,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 61295,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 61299,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 61300,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 61307,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 82880,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 82887,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 82892,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 82893,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 82901,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 106819,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 106826,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 106831,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 106832,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 106841,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 132722,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 132730,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 132737,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 132738,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 132751,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 160583,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 160592,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 160599,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 160600,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 160614,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 190818,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Parsey Merdad",
      "reporting_owner_cik": "0001792150",
      "reporting_owner_position": "Chief Medical Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20229",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "69701"
    },
    {
      "id": 190827,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "19006",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "96891"
    },
    {
      "id": 190834,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2024-01-31",
      "transaction_shares": "20086",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "81687"
    },
    {
      "id": 190835,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-31",
      "transaction_shares": "4646",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "11728"
    },
    {
      "id": 190851,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2024-01-31",
      "transaction_shares": "50870",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "368147"
    },
    {
      "id": 3950,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 13078,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 25655,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 41970,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 61291,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 82883,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 106822,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 132725,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 160586,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    },
    {
      "id": 190821,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2024-01-25",
      "transaction_shares": "514",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "7276"
    }
  ]
}